紫光國微(002049.SZ):“18國微01”停牌兩天 調整投資者適當性安排
格隆匯11月13日丨紫光國微(002049.SZ)公佈,根據《深圳證券交易所債券市場投資者適當性管理辦法》的相關規定,“18國微01”公司債券將被調整投資者適當性安排,由原“僅限合格投資者參與交易”調整為“僅限合格機構投資者參與交易”,原持有上述債券的非合格機構投資者可以選擇持有到期或者賣出債券,非合格機構投資者不得再買入上述債券。
同時,“18國微01”公司債券將在2020年11月13日至2020年11月16日停牌兩天,並於2020年11月17日開市起復牌。自復牌之日起,“18國微01”公司債券交易實施上述投資者適當性安排,僅限合格機構投資者參與交易。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.